Exercise Performance Recovery
Conditions
Brief summary
Part one of this study will consist of baseline (BL) testing, 28 days of daily supplementation with XSurge, and an exercise protocol. The acute exercise protocol consists of five visits, of which, the first visit will consist of maximal strength testing. The remaining visits will consist of performance testing and muscle evaluation. Phase two of this study will consist of six weeks of supervised resistance training along with supplementation of XSurge. Following the six weeks of training, subjects will complete a second acute exercise protocol. Measures to be evaluated will consist of performance testing and muscle evaluation.
Interventions
DIETARY_SUPPLEMENTXSurge
During part one of the study, 28 days of supplementation with XSurge will be provided. During the second part of the study 6 weeks of supplementation with XSurge will accompany a training program.
OTHERPlacebo: Microcrystalline Cellulose
Sponsors
Kemin Foods LC
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes
Inclusion criteria
* Recreationally active. * Subject is judged by the Investigator to be healthy and free of any physical limitations * Subject is male 18-35 y of age, inclusive * Subject has a body mass index of 18.0-34.9 kg/m2 * Subject is willing to maintain habitual diet * Subject is willing to abstain from dietary supplementation * Subject understands the study procedures and signs forms providing informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigators
Exclusion criteria
* Subject is currently or will be enrolled in another clinical trial. * Subject has a history or presence of a clinically relevant cardiac, renal, hepatic, endocrine (including diabetes mellitus), pulmonary, biliary, gastrointestinal, pancreatic, or neurologic disorder. * Subject has a history or presence of cancer in the prior 2 years, except for non-melanoma skin cancer. * Subject is unable to perform physical exercise * Subject is a current smoker or has quit within the last 6 months * Subject is engaged in an extreme diet including but not limited to, Atkins, South Beach, Intermittent Fasting, etc. * Subject is allergic to the study product or placebo * Subject is taking any other nutritional supplement or performance enhancing drug * Subjects that have donated blood or plasma within the previous week * Subject has any chronic illness that causes continuous medical care * Taking any type of prescription or over-the-counter medication including but not limited to corticosteroids, non-steroidal anti-inflammatory drugs, and antibiotics within the 14 days prior to the screening visit.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Strength as measured by Peak Torque (Biodex) | Part 1-Change from baseline after 28 days of supplementation; Part 2-Change from baseline after 6 weeks of supplementation plus exercise |
| Biomarkers (Cortisol and Creatine Phosphokinase) | Part 1-Change from baseline after 28 days of supplementation; Part 2-Change from baseline after 6 weeks of supplementation plus exercise |
Secondary
| Measure | Time frame |
|---|---|
| Subjective Feelings of Recovery (Likert Scale) | Part 1-Change from baseline after 28 days of supplementation; Part 2-Change from baseline after 6 weeks of supplementation plus exercise |
| Muscle Soreness (VAS) | Part 1-Change from baseline after 28 days of supplementation; Part 2-Change from baseline after 6 weeks of supplementation plus exercise |
Countries
United States
Outcome results
None listed